H.S. Rugo

1. Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study
   2018/11/22 by Sylvia Adams, S. Adams, Sherene Loi +36 · 3 citations
   Biochemistry, Genetics and Molecular Biology · Medicine · #Advanced Breast Cancer Therapies #Breast Cancer Treatment Studies #Cancer Immunotherapy and Biomarkers
2. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
   2020/12/01 by F. Cardoso, S. Paluch-Shimon, E. Senkus +42 · 2 citations
3. Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study
   2019/03/01 by S. Adams, P. Schmid, H.S. Rugo +18 · 1 citation